Jonathan Miller interviews Bill Bookout, President of the National Animal Supplements Council, about an exciting new study on the impact of hemp and CBD on household pets. If you have questions about the episode or ideas for Hemp related topics, email us at hemplegallyspeaking@fbtlaw.com.

Hemp Industry questions covered in the episode:

1. What is the current marketplace for hemp supplements for pets?
2. How are pet owners finding value for administering hemp and CBD?
3. What were the results of the new study NASC commissioned on the use of hemp and CBD for pets?
4. How will this study shape future regulatory action from the FDA?
5. What advice do you give to pet owners on hemp and CBD pet products?

Jonathan Miller interviews Uttam Dhillon, the former Acting Administrator of the Drug Enforcement Administration and current partner at Frost Brown Todd, about federal law enforcement views of hemp and cannabis, and the potential rescheduling and descheduling of cannabis. If you have questions about the episode or ideas for Hemp related topics, email us at hemplegallyspeaking@fbtlaw.com.

Hemp Industry questions covered in the episode:

1. As the DEA head when hemp was legalized, why was the agency so concerned about hemp prior to legalization?
2. What are the prospects of rescheduling cannabis, and what would serve as the regulatory framework?
3. Why is law enforcement so generally opposed to cannabis legalization?
4. Why does the DEA care about hemp/cannabis when there are so much more dangerous drugs affecting the country like heroin or fentanyl?
5. What are the most common misperceptions about DEA agent and their motivations?

Jonathan Miller interviews Jim Carroll, the former White House "Drug Czar" and current partner at Frost Brown Todd, about federal law enforcement views of hemp and cannabis, and the potential rescheduling of marijuana. If you have questions about the episode or ideas for Hemp related topics, email us at hemplegallyspeaking@fbtlaw.com.

Hemp Industry questions covered in the episode:

1. How does federal law enforcement view cannabis and its potential legalization?
2. Are there more nuanced views toward hemp and CBD at the federal level?
3. What is the status of the Biden Administration's potential efforts to reschedule cannabis at Schedule 3, and what would it mean?
4. What would be an appropriate regulatory regime for cannabis under Schedule 3?
5. How should the cannabis industry prepare for rescheduling?
6. How would rescheduling impact hemp and hemp extracts?